Pembrolizumab-Induced Aplastic Anemia Successfully Treated With Thrombopoietin Receptor Agonist in a Patient With Lung Adenocarcinoma: A Case Report and Literature Review. [PDF]
CureusNamba K +4 more
europepmc +1 more source
Comparison of the real-world efficacy and safety of romiplostim and recombinant human thrombopoietin (rhTPO) in chemotherapy-induced thrombocytopenia. [PDF]
BMC CancerCheng Y +7 more
europepmc +1 more source
Recombinant human thrombopoietin for chronic liver disease-associated thrombocytopenia with or without concomitant infections: a real-world retrospective study. [PDF]
Front PharmacolWei X +6 more
europepmc +1 more source
Cost-effectiveness of hetrombopag, eltrombopag, and avatrombopag for chronic immune thrombocytopenia in China: a cost-utility analysis. [PDF]
Front Public HealthJin S +6 more
europepmc +1 more source
Effectiveness of Rituximab, Belimumab, and Thrombopoietin Receptor Agonists in Refractory Immune Thrombocytopenia Associated With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis. [PDF]
CureusOhta R, Ryu Y, Ichinose K.
europepmc +1 more source
Coombs-Negative Hemolytic Anemia and Thrombocytopenia Associated With Sarcoidosis Confined to the Spleen and Bone Marrow: A Case Report. [PDF]
CureusUemura Y, Togitani K, Nakashima J.
europepmc +1 more source
Thrombopoietin Receptor Agonists Plus Immunosuppressive Therapy in Aplastic Anaemia: A Systematic Review and Meta-Analysis. [PDF]
EJHaemAshrafi E +5 more
europepmc +1 more source
Effect of Thrombopoietin Receptor Agonist Romiplostim on the Ionizing Radiation-Induced Premature Aging. [PDF]
Pharmacol Res PerspectYamaguchi M +3 more
europepmc +1 more source
No significant increase in thrombotic risk following the widespread adoption of TPO-RAs in ITP: A comparative study. [PDF]
Glob Med GenetWang Y +8 more
europepmc +1 more source